Search

Your search keyword '"Benito, Daniel A."' showing total 618 results

Search Constraints

Start Over You searched for: Author "Benito, Daniel A." Remove constraint Author: "Benito, Daniel A."
618 results on '"Benito, Daniel A."'

Search Results

3. Phenotype-driven genomics enhance diagnosis in children with unresolved neuromuscular diseases

5. Mutations of GEMIN5 are associated with coenzyme Q10 deficiency: long-term follow-up after treatment

6. Correction: Phenotype-driven genomics enhance diagnosis in children with unresolved neuromuscular diseases

9. Advancing the Understanding of Vesicle-Associated Membrane Protein 1-Related Congenital Myasthenic Syndrome: Phenotypic Insights, Favorable Response to 3,4-Diaminopyridine, and Clinical Characterization of Five New Cases

11. Prophylaxis

12. Geospatial and Spatio-Temporal Models

13. Management of COVID-19 Data for the FASSSTER Platform

14. Variants in DTNA cause a mild, dominantly inherited muscular dystrophy

16. Clinical, genetic, epidemiologic, evolutionary, and functional delineation of TSPEAR-related autosomal recessive ectodermal dysplasia 14

17. A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing

19. Systematic Collaborative Reanalysis of Genomic Data Improves Diagnostic Yield in Neurologic Rare Diseases

21. Inferring disease course from differential exon usage in the wide titinopathy spectrum.

22. Éléments de données communs pour l'arthrogrypose multiple congénitale: Un cadre international.

23. Elementos de datos comunes para la artrogriposis múltiple congénita: Un marco internacional.

24. Common data elements for arthrogryposis multiplex congenita: An international framework.

27. Congenital LMNA-Related Muscular Dystrophy in Paediatrics: Cardiac Management in Monozygotic Twins

28. Effects of HMGCR deficiency on skeletal muscle development

29. Improving Diagnostic Precision: Phenotype-Driven Analysis Uncovers a Maternal Mosaicism in an Individual with RYR1-Congenital Myopathy

31. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

43. A Novel Missense Variant in the NKX2-1 Homeodomain Prevents Transcriptional Rescue by TAZ.

50. Early and long-term effect of the treatment with pyridostigmine in patients with GMPPB-related congenital myasthenic syndrome

Catalog

Books, media, physical & digital resources